Polymerase I as a Target for Treating Neurodegenerative Disorders
Mark S. LeDoux(University of Tennessee Health Science Center)
Cited by 1
Related Papers
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
|Neurology|2016|137
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
|Unknown|2017|28
Polymerase I as a Target for Treating Neurodegenerative Disorders
|Biomedicines|2024|4